Get started
Author

Raphaël Thuillet

Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
2016 · Christophe Guignabert, Carole Phan, et al. · Journal of Clinical Investigation · 287
PDF
Increased Pericyte Coverage Mediated by Endothelial-Derived Fibroblast Growth Factor-2 and Interleukin-6 Is a Source of Smooth Muscle–Like Cells in Pulmonary Hypertension
2014 · Nicolas Ricard, Ly Tu, et al. · Circulation · 225
Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex
2015 · Morane Le Hiress, Ly Tu, et al. · American Journal of Respiratory and Critical Care Medicine · 214
Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension
2018 · Yuichi Tamura, Carole Phan, et al. · Journal of Clinical Investigation · 182
PDF
Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension
2019 · Ly Tu, Agnès Desroches-Castan, et al. · Circulation Research · 141
PDF
Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension
2016 · Alice Huertas, Carole Phan, et al. · CHEST Journal · 91
Lineage Tracing Reveals the Dynamic Contribution of Pericytes to the Blood Vessel Remodeling in Pulmonary Hypertension
2020 · Jennifer Bordenave, Ly Tu, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 89
PDF
Neutralization of CXCL12 attenuates established pulmonary hypertension in rats
2019 · Jennifer Bordenave, Raphaël Thuillet, et al. · Cardiovascular Research · 89
PDF
Dasatinib increases endothelial permeability leading to pleural effusion
2018 · Carole Phan, Etienne-Marie Jutant, et al. · European Respiratory Journal · 84
PDF
Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension
2023 · Christophe Guignabert, Laurent Savale, et al. · Circulation · 79
PDF
Leptin signalling system as a target for pulmonary arterial hypertension therapy
2015 · Alice Huertas, Ly Tu, et al. · European Respiratory Journal · 77
PDF
Serum and pulmonary uric acid in pulmonary arterial hypertension
2021 · Laurent Savale, Satoshi Akagi, et al. · European Respiratory Journal · 64
PDF
Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension
2018 · Nina Rol, Michiel A de Raaf, et al. · Cardiovascular Research · 49
PDF
Additive protective effects of sacubitril/valsartan and bosentan on vascular remodelling in experimental pulmonary hypertension
2020 · Marie-Camille Chaumais, Mohamed Reda Amar Djessas, et al. · Cardiovascular Research · 47
PDF
Renal Denervation Reduces Pulmonary Vascular Remodeling and Right Ventricular Diastolic Stiffness in Experimental Pulmonary Hypertension
2017 · Denielli da Silva Gonçalves Bos, Chris Happé, et al. · JACC Basic to Translational Science · 43
PDF
Loss of lung microvascular endothelial Piezo2 expression impairs NO synthesis, induces EndMT, and is associated with pulmonary hypertension
2022 · Siyu Tian, Zongye Cai, et al. · American Journal of Physiology-Heart and Circulatory Physiology · 41
Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension
2018 · Paul-Benoit Poble, Carole Phan, et al. · The FASEB Journal · 40
PDF
Mineralocorticoid Receptor Antagonism by Finerenone Attenuates Established Pulmonary Hypertension in Rats
2022 · Ly Tu, Raphaël Thuillet, et al. · Hypertension · 36
PDF
Effects of B Cell Depletion by CD19‐Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis
2023 · Jérôme Avouac, Anne Cauvet, et al. · Arthritis & Rheumatology · 32
PDF
Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis
2018 · Sven Günther, Jennifer Bordenave, et al. · International Journal of Molecular Sciences · 32
PDF
Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension
2018 · Morane Le Hiress, Bernardin Akagah, et al. · Journal of Medicinal Chemistry · 31
Disrupted BMP-9 Signaling Impairs Pulmonary Vascular Integrity in Hepatopulmonary Syndrome
2024 · Fabien Robert, Marie-Caroline Certain, et al. · American Journal of Respiratory and Critical Care Medicine · 30
PDF
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models
2022 · Cindy Orvain, Anne Cauvet, et al. · Arthritis Research & Therapy · 27
PDF
Connexin-43 is a promising target for pulmonary hypertension due to hypoxaemic lung disease
2019 · Claire Bouvard, Nafiisha Genet, et al. · European Respiratory Journal · 27
PDF
Driving Role of Interleukin‐2–Related Regulatory CD4 + T Cell Deficiency in the Development of Lung Fibrosis and Vascular Remodeling in a Mouse Model of Systemic Sclerosis
2022 · Camelia Frantz, Anne Cauvet, et al. · Arthritis & Rheumatology · 26
Works count: 102
Citation count: 2,268
H-index: 25
I10-index: 33
Year
Topic
Type